News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,172 Results
Type
Article (1922)
Company Profile (2)
Press Release (70248)
Section
Business (21470)
Career Advice (9)
Deals (4552)
Drug Development (8186)
FDA (1816)
Job Trends (805)
News (37073)
Policy (3569)
Tag
Academia (96)
Accelerated approval (2)
Allergies (15)
Alliances (8166)
ALS (12)
Alzheimer's disease (156)
Antibody-drug conjugate (ADC) (63)
Approvals (1925)
Artificial intelligence (25)
Autoimmune disease (11)
Automation (1)
Bankruptcy (8)
Best Places to Work (591)
Biosimilars (63)
Biotechnology (5)
Bladder cancer (26)
Brain cancer (5)
Breast cancer (52)
Cancer (485)
Cardiovascular disease (18)
Career advice (9)
CAR-T (12)
Cell therapy (47)
Cervical cancer (3)
Clinical research (7455)
Collaboration (244)
Compensation (17)
Complete response letters (5)
COVID-19 (194)
C-suite (63)
Cystic fibrosis (6)
Data (582)
Depression (11)
Diabetes (30)
Diagnostics (622)
Digital health (4)
Drug discovery (33)
Drug pricing (1)
Duchenne muscular dystrophy (29)
Earnings (7948)
Events (7367)
Executive appointments (60)
FDA (2205)
Fibrodysplasia Ossificans Progressiva (1)
Funding (118)
Gene editing (5)
Generative AI (1)
Gene therapy (29)
GLP-1 (64)
Government (237)
Grass and pollen (1)
Guidances (38)
Healthcare (1082)
HIV (1)
Huntington's disease (2)
IgA nephropathy (18)
Immunology and inflammation (5)
Immuno-oncology (4)
Indications (12)
Infectious disease (208)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (32)
IPO (1638)
Job creations (241)
Job search strategy (9)
JPM (3)
Layoffs (6)
Legal (953)
Liver cancer (18)
Lung cancer (90)
Lymphoma (36)
Manufacturing (84)
MASH (12)
Medical device (1160)
Medtech (1167)
Mergers & acquisitions (3075)
Metabolic disorders (72)
Multiple sclerosis (16)
NASH (1)
Neurodegenerative disease (25)
Neuropsychiatric disorders (5)
Neuroscience (265)
NextGen: Class of 2026 (219)
Non-profit (63)
Obesity (25)
Opinion (1)
Ovarian cancer (21)
Pain (13)
Pancreatic cancer (15)
Parkinson's disease (32)
Partnered (3)
Patents (50)
Patient recruitment (47)
Peanut (1)
People (5096)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (2008)
Phase 2 (3134)
Phase 3 (2825)
Pipeline (571)
Policy (2)
Postmarket research (251)
Preclinical (691)
Press Release (2)
Prostate cancer (20)
Radiopharmaceuticals (22)
Rare diseases (60)
Real estate (605)
Regulatory (2878)
Reports (6)
Research institute (97)
RNA editing (2)
RSV (2)
Schizophrenia (16)
Series A (23)
Series B (21)
Service/supplier (1)
Sickle cell disease (6)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (12)
Vaccines (39)
Venture capital (5)
Weight loss (5)
Women's health (4)
Date
Today (1)
Last 7 days (48)
Last 30 days (208)
Last 365 days (2746)
2026 (289)
2025 (2704)
2024 (3265)
2023 (3822)
2022 (7017)
2021 (6377)
2020 (5872)
2019 (3871)
2018 (3014)
2017 (3571)
2016 (3180)
2015 (4043)
2014 (3038)
2013 (2601)
2012 (2776)
2011 (2904)
2010 (2663)
Location
Africa (88)
Alabama (3)
Arizona (11)
Asia (21970)
Australia (2461)
California (636)
Canada (372)
China (366)
Colorado (5)
Connecticut (21)
Delaware (6)
Europe (13050)
Florida (60)
Georgia (13)
Illinois (30)
India (34)
Indiana (36)
Japan (240)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (103)
Massachusetts (482)
Michigan (7)
Minnesota (34)
Missouri (3)
Nebraska (2)
Nevada (9)
New Hampshire (1)
New Jersey (380)
New York (226)
North Carolina (90)
Northern California (270)
Ohio (3)
Oregon (1)
Pennsylvania (106)
Rhode Island (1)
South America (108)
Southern California (298)
Tennessee (1)
Texas (52)
United States (2408)
Utah (24)
Virginia (47)
Washington D.C. (3)
Washington State (47)
Wisconsin (7)
72,172 Results for "neuraxis ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
November 13, 2025
·
4 min read
Press Releases
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
November 12, 2025
·
8 min read
Press Releases
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
November 5, 2025
·
3 min read
Press Releases
NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 18, 2025
·
3 min read
Press Releases
NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
October 27, 2025
·
4 min read
Press Releases
NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
August 12, 2025
·
9 min read
Press Releases
NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
August 6, 2025
·
3 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
QureBio Ltd. to Present at ASCO 2026 its Q-1802 Phase II Clinical Results
January 29, 2026
·
3 min read
BioMidwest
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS) today announced the results of a multicenter registry study on IB-Stim for pediatric disorders of gut-brain interaction (DGBI). IB-Stim is NeurAxis’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology therapy.
March 27, 2024
·
5 min read
1 of 7,218
Next
